Northwest Biotherapeutics | NWBO - Marktkapitalisierung





Marktkapitalisierung Veränderung Datum
Agenus USD 107M 16M 2025-12
AstraZeneca USD 288.15B 55.08B 2025-12
Bristol-Myers Squibb USD 109.81B 18.01B 2025-12
Celldex Therapeutics USD 1.81B 87M 2025-12
Eisai JPY 1.31T 140.95B 2025-12
Infinity Pharmaceuticals USD 0 0 2026-04
Merck USD 261.26B 51.62B 2025-12
Northwest Biotherapeutics USD 246M 110M 2026-04
Pfizer USD 141.57B 6.48B 2025-12
Plus Therapeutics USD 17M 54M 2026-04
Roche Holding CHF 266.34B 55.46B 2025-12